Ecolab Inc.

ECL Basic Materials Specialty Chemicals

Ecolab Inc.’s revenue for fiscal 2025 (year ended December 2025) was $16.1 billion, up 2.16% from fiscal 2024.

Revenue
+12.7%
EPS
−4.37%
Free cash flow
−15.6%
Total debt
+63.5%

Quarter to September 2026, against a year earlier

306.11 8.90 −2.83%
Market cap
$85.8B
P/E
41.3×
Fwd P/E
40.1×
Dividend yield
0.95%
F-score
6/9
Altman Z
4.76
Beneish M
−2.51
Dividend safety
89/100

Ecolab Inc. (ECL) Business Profile

Updated · Covers results through FY2025 · How this is made

What it does

Ecolab is a Saint Paul-headquartered company led by Chairman and Chief Executive Officer Christophe Beck. It supplies water treatment, cleaning, sanitation, infection-prevention, pest-elimination and contamination-control solutions. Its model combines chemicals and other consumables with dispensing or monitoring equipment, digital tools and field service.

Global Water serves industrial customers with programs for cooling water, boiler water, wastewater, ultra-pure water and process water. It also supplies cleaning, sanitation and water programs to food and beverage processors, farms, breweries and pulp-and-paper producers. Global Institutional & Specialty supplies cleaners, sanitizers, food-safety products, dishwashing and laundry programs, infection-prevention products, and related equipment to foodservice, hospitality, healthcare, education, government and retail customers.

Global Pest Elimination detects, prevents and eliminates rodents and insects for commercial sites. Global Life Sciences supplies cleaning, contamination-control, purification and decontamination products and systems to pharmaceutical, personal-care, medical-device and related manufacturers. Its offerings include products sold under the Ecolab, Nalco, 3D TRASAR, Kay, Purolite and Bioquell names.

Management said on the call that Ecolab also combines its water, hygiene, pest and digital capabilities for customers in data centers and microelectronics, including liquid cooling and circular-water applications.

How it makes money

Ecolab has four reportable segments: Global Water, Global Institutional & Specialty, Global Pest Elimination and Global Life Sciences. It primarily earns revenue from product and sold-equipment sales when contractual obligations are satisfied. Pest Elimination differs because most of its revenue comes from services recognized over the service period.

Global Water sells treatment chemicals, process aids, digital monitoring, control equipment and related programs. Its Light & Heavy business addresses industrial water and process applications; Food & Beverage supplies cleaning, sanitation, water and animal-health programs; and Paper provides water and process applications for papermaking. Global Institutional & Specialty sells cleaning, sanitizing, warewashing, laundry, infection-prevention and food-safety programs, including some leased dishwashing-machine programs with maintenance. Life Sciences mainly sells products and equipment, while Pest Elimination provides ongoing commercial service.

Direct field and corporate-account salespeople sell most offerings and help customers use products and systems. This support links product sales, monitoring equipment and customer service. Management said on the call that the company is integrating Cool IT’s liquid-cooling technologies with its 3D TRASAR liquid-monitoring technology, and it describes the data-center offering as cooling delivered end to end rather than individual components.

FY2025 sales were $16.1 billion; Q3 2026 organic sales growth was 7% and organic operating-income margin was 19.6%.

Customers and how it sells

Ecolab serves customers in more than 170 countries and 40 industries. Its industrial and water customers include manufacturers, food and beverage processors, transportation companies, chemical producers, power generators, refiners, petrochemical companies, mining businesses, data centers, microelectronics producers and pulp-and-paper manufacturers. Its institutional customers include restaurants, quick-service restaurant chains, hotels, hospitals, long-term care centers, schools, retailers and commercial facilities. Life Sciences serves pharmaceutical, animal-health, cosmetics, biologics, dialysis, blood-purification and medical-device manufacturers.

The company directly operates in approximately 100 countries outside the United States. The United States is Pest Elimination’s largest operation. Ecolab uses direct field sales and corporate-account teams as its principal channels, supplemented in certain markets by distributors, agents and licensees. Distributors are particularly relevant to farm products, quick-service restaurants, foodservice logistics, healthcare and janitorial customers.

No customer or distributor represented 10% or more of consolidated revenue in 2025, 2024 or 2023. Specialty nevertheless remains largely dependent on a limited number of major quick-service restaurant chains, franchisees and large food-retail customers. Warewashing products represented approximately 13% of consolidated net sales in 2025.

Suppliers and costs

Ecolab manufactures most products and related equipment in company-operated facilities. It also uses contract manufacturers, buys certain products and equipment from third parties, and distributes from plants, distribution centers and third-party logistics providers. Transport uses common carriers, company vehicles and distributors.

Its manufacturing inputs include inorganic chemicals such as alkalis, acids, biocides, phosphonates, silicates and salts, and organic chemicals such as alcohols, amines, surfactants, solvents, monomers and polymers. It also buys packaging and components for specialized equipment. Pest Elimination purchases pesticides as finished products from producers or distributors.

The company purchases more than 10,000 raw materials. Its largest single raw material represents approximately five percent of raw-material purchases. Most materials are bought on annual contracts and are generally available from diverse global suppliers; global sourcing can shift purchasing or production locations to manage product costs. Management said on the call that commodity costs are expected to remain high and that it expects pricing execution and supply-chain management to offset higher costs.

From revenue to operating income, FY2025
  1. Revenue$16.1B
  2. Cost of revenue−$8.9B
  3. Selling, general and administrative−$4.3B
  4. Other operating costs−$154.9M
  5. Operating income$2.7B

Competitive position

Ecolab competes in Global Water against a small number of large companies and smaller regional or specialized providers. The company competes through demonstrated customer value, technical expertise, chemistry, digital technology, monitoring, detection, dosing and metering equipment, global support and field service. In institutional, specialty and pest elimination, it faces both larger national or international competitors and many regional or local providers. Life Sciences competes against mid-size and regional competitors in Europe, two large competitors and other providers in North America, and fragmented providers elsewhere.

The available business descriptions identify no competitor by name. Ecolab states that its trademarks related to Ecolab, Nalco and 3D TRASAR are material across its reportable segments and that it expects to maintain them indefinitely. It has also invested in process-control and monitoring equipment and technology used to dispense products and monitor water systems.

Our reading: Ecolab’s field-service network, direct selling and customer-specific operating support are a meaningful moat because products, equipment, monitoring and service are delivered together across multiple segments. [item1]

Our reading: Digital monitoring and process expertise strengthen that moat where customers require water treatment, food safety, contamination control or pest monitoring, but regional competitors remain present in several markets. [item1]

Our reading: Brand and intellectual-property protection support differentiation, although the company does not consider its overall business materially dependent on any individual patent or trademark. [item1]

Growth opportunities

Ecolab’s growth initiatives include selling more of its water, hygiene, pest and digital offerings to existing large customers, expanding digital monitoring, increasing pest-device deployment, building Life Sciences capacity, and serving data centers and microelectronics. The company sizes its opportunity with its 35 largest customers at $3.5 billion. Management said on the call that it had generated more than $400 million of sales growth with those customers since launching One Ecolab.

Management said on the call that Pest Intelligence connects more than 800,000 devices and that the company sees $3.0 billion of additional cross-sell opportunity in pest elimination. It also said it intends to increase North American institutional selling capacity and integrate hygiene, water, pest intelligence and audit offerings for hospitality, foodservice, quick-service restaurant and retail customers.

In Life Sciences, management said on the call that a new China plant supports Asian demand. In global high-tech, it said data-center cooling and circular water for microelectronics are growth areas. It said Cool IT sales more than doubled after joining Ecolab, while Ovivo’s ultra-pure water systems can recycle more than 80% of water used in a semiconductor fab. Management said its global high-tech ambition is to grow sales more than 25% annually, reach $4 billion in sales by 2030 and deliver a 25% operating-income margin.

Management also said Ecolab Digital is expected to support long-term growth of more than 20%.

Revenue by fiscal year
  1. $12.7BFY2021
  2. $14.2BFY2022
  3. $15.3BFY2023
  4. $15.7BFY2024
  5. $16.1BFY2025

Structural risks

  • Raw-material, energy and utility availability and pricing can affect results. Management said on the call that commodity costs are expected to remain high.

  • International operations expose Ecolab to trade and investment-law changes, foreign-exchange movements, tax and regulatory changes, political and economic conditions, and potentially lower profitability because of smaller scale, import costs and distributor reliance.

  • Chemical, product, environmental, pesticide, biocide, medical-device and pharmaceutical regulations can require testing, registrations, reformulations, labeling changes and additional compliance spending. Regulatory changes can interrupt supply or limit sales of products and services.

  • Debt obligations can require operating cash flow to be used for principal and interest, reduce flexibility for capital investment or acquisitions, and create interest-rate exposure on floating-rate debt. As of December 31, 2025, Ecolab had approximately $8.2 billion of outstanding indebtedness, including approximately $1.5 billion of floating-rate debt.

  • The company identifies acquisition integration as a strategic risk. Management said on the call that it is integrating recently acquired Cool IT and Ovivo businesses into its data-center and microelectronics activities.

  • Specialty remains reliant on a limited group of major quick-service restaurant chains, franchisees and large food-retail customers, while North American restaurant traffic declined by mid-single digits, management said on the call.

Bottom line

Our reading

Our reading: Ecolab is a service-led specialty-chemicals business whose consumables, equipment, digital monitoring and field support address water, hygiene, food safety, pest control and contamination control. [item1]

Our reading: Its operating model is supported by direct selling, recurring pest services and installed monitoring or dispensing systems, while most revenue remains product and equipment sales recognized at delivery. [item1]

Our reading: High-tech cooling and semiconductor water applications add new growth initiatives, but commodity inflation, regulation, international operations, debt and acquisition integration remain material operating constraints. [call_prepared; item1; item1a]